Literature DB >> 27774664

Assessing psychological and supportive care needs in glioma patients - feasibility study on the use of the Supportive Care Needs Survey Short Form (SCNS-SF34-G) and the Supportive Care Needs Survey Screening Tool (SCNS-ST9) in clinical practice.

M Renovanz1, A-K Hickmann2,3, J Coburger4, K Kohlmann1, M Janko1, A-K Reuter1, N Keric1, M Nadji-Ohl3, J König5, S Singer5,6, A Giese1, M Hechtner5,6,7.   

Abstract

Neuro-oncological patients experience high symptom and psychosocial burden. The aim was to test feasibility and practicability of the Supportive Care Needs Survey Short Form (SCNS-SF34-G) and the SCNS-Screening Tool (SCNS-ST9) to assess supportive care needs of neuro-oncological patients in clinical routine. A total of 173 patients, most with a primary diagnosis of high-grade glioma (81%), were assessed first using SCNS-SF34-G in comparison to two well-established patient-reported outcome measures, the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQC30 + QLQ-BN20) and Distress Thermometer (DT). In a follow-up assessment, SCNS-ST9 was used in a subgroup (n = 90). Questionnaires were completed either with personal guidance offered (group A) or by patients alone (group B). Feasibility was compared between instruments and groups for possible associations with patient and treatment-related factors. Missing values occurred in similar frequencies in all instruments. Errors in completion occurred in SCNS-SF34-G in 20% and in SCNS-ST9 in 16%; difficulties in completion were observed more often in SCNS-SF34-G and SCNS-ST9 (39%) compared to DT and EORTC (13%, p < .001). Distress was found to be associated with difficulties in completion of SCNS (OR 1.4, [95% CI 1.1-1.9], p = .013). SCNS-SF34 and SCNS-ST9 are suitable tools for glioma patients as long as personal guidance is offered.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  glioma; needs assessment; questionnaire; supportive care needs

Mesh:

Year:  2016        PMID: 27774664     DOI: 10.1111/ecc.12598

Source DB:  PubMed          Journal:  Eur J Cancer Care (Engl)        ISSN: 0961-5423            Impact factor:   2.520


  12 in total

1.  Initial psycho-oncological counselling in neuro-oncology: analysis of topics and needs of brain tumour patients.

Authors:  Stephanie Schipmann; Eric Suero Molina; Anna Frasch; Walter Stummer; Dorothee Wiewrodt
Journal:  J Neurooncol       Date:  2017-11-17       Impact factor: 4.130

2.  Clinical routine assessment of palliative care symptoms and concerns and caregiver burden in glioblastoma patients: an explorative field study.

Authors:  Matthias Seibl-Leven; Christian von Reeken; Roland Goldbrunner; Stefan Grau; Maximilian Ingolf Ruge; Norbert Galldiks; Veronika Dunkl; Martin Kocher; Raymond Voltz; Heidrun Golla
Journal:  J Neurooncol       Date:  2018-02-20       Impact factor: 4.130

3.  The interplay among psychological distress, the immune system, and brain tumor patient outcomes.

Authors:  Sebastian Otto-Meyer; Jan Lumibao; Eugene Kim; Erik Ladomersky; Lijie Zhai; Kristen L Lauing; Denise M Scholtens; Frank Penedo; Christina Amidei; Rimas V Lukas; Derek A Wainwright
Journal:  Curr Opin Behav Sci       Date:  2019-02-26

4.  Factors associated with supportive care needs in glioma patients in the neuro-oncological outpatient setting.

Authors:  Mirjam Renovanz; Marlene Hechtner; Mareile Janko; Karoline Kohlmann; Jan Coburger; Minou Nadji-Ohl; Jochem König; Florian Ringel; Susanne Singer; Anne-Katrin Hickmann
Journal:  J Neurooncol       Date:  2017-05-19       Impact factor: 4.130

5.  Evaluation of the psychological burden during the early disease trajectory in patients with intracranial tumors by the ultra-brief Patient Health Questionnaire for Depression and Anxiety (PHQ-4).

Authors:  Mirjam Renovanz; Sari Soebianto; Helena Tsakmaklis; Naureen Keric; Minou Nadji-Ohl; Manfred Beutel; Florian Ringel; Daniel Wollschläger; Anne-Katrin Hickmann
Journal:  Support Care Cancer       Date:  2019-03-23       Impact factor: 3.603

6.  Effect of early palliative care for patients with glioblastoma (EPCOG): a randomised phase III clinical trial protocol.

Authors:  Heidrun Golla; Charlotte Nettekoven; Claudia Bausewein; Jörg-Christian Tonn; Niklas Thon; Berend Feddersen; Oliver Schnell; Christopher Böhlke; Gerhild Becker; Roman Rolke; Hans Clusmann; Ulrich Herrlinger; Lukas Radbruch; Hartmut Vatter; Erdem Güresir; Stephanie Stock; Dirk Müller; Daniele Civello; Irini Papachristou; Martin Hellmich; Stefanie Hamacher; Raymond Voltz; Roland Goldbrunner
Journal:  BMJ Open       Date:  2020-01-07       Impact factor: 2.692

7.  Compliance with patient-reported outcome assessment in glioma patients: predictors for drop out.

Authors:  Mirjam Renovanz; Marlene Hechtner; Karoline Kohlmann; Mareile Janko; Minou Nadji-Ohl; Susanne Singer; Florian Ringel; Jan Coburger; Anne-Katrin Hickmann
Journal:  Neurooncol Pract       Date:  2017-10-31

8.  Supportive Care Needs in Glioma Patients and Their Caregivers in Clinical Practice: Results of a Multicenter Cross-Sectional Study.

Authors:  Mirjam Renovanz; Dorothea Maurer; Heike Lahr; Elke Weimann; Monika Deininger; Christian Rainer Wirtz; Florian Ringel; Susanne Singer; Jan Coburger
Journal:  Front Neurol       Date:  2018-09-11       Impact factor: 4.003

9.  Glioma patients in outpatient care-optimization of psychosocial care in neuro-oncological patients (GLIOPT): Protocol for a cluster randomized controlled trial.

Authors:  Mirjam Renovanz; Melina Hippler; Martin Voss; Jens Wehinger; Almuth F Keßler; Jens Gempt; Minou Nadji-Ohl; Carolin Weiß Lucas; Marion Rapp; Martin Misch; Jan Coburger; Marcus Mehlitz; Jürgen Meixensberger; Naureen Keric; Ghazaleh Tabatabai; Maria Blettner; Melanie Schranz; Susanne Singer
Journal:  Trials       Date:  2020-05-27       Impact factor: 2.279

10.  Health-related quality of life and distress in elderly vs. younger patients with high-grade glioma-results of a multicenter study.

Authors:  Mirjam Renovanz; Anne-Katrin Hickmann; Minou Nadji-Ohl; Naureen Keric; Elke Weimann; Christian Rainer Wirtz; Susanne Singer; Florian Ringel; Jan Coburger
Journal:  Support Care Cancer       Date:  2020-02-14       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.